20 March 2017 in Frontiers in Immunology
JCJulio E. Castañeda-Delgado
Julio E. Castañeda-Delgado
+7
Rheumatoid arthritis is an inflammatory debilitating disease that affects the joints in the early and productive phases of an individual’s life. Several cytokines have been linked to the disease pathogenesis and are known to contribute to the inflammatory state characteristic of RA. The participation of type I interferon (IFN) in the pathogenesis of the disease has been already described as well as the identity of the genes that are regulated by this molecule, which are collectively known as the type I IFN signature. These genes have several functions associated to apoptosis, transcriptional regulation, protein degradation, Th2 cell induction, B cell proliferation, etc. The present article evaluates the expression of the IFN signature in different stages of disease and their correlation with the levels of antibodies against citrullinated proteins (ACPA) and carbamylated proteins (Anti-CarP). Methods: Samples from individuals with early and established RA, high risk individuals (ACPA+ and ACPA-) and healthy controls were recruited at “Unidad de Artritis y Rheumatismo” (Rheumatism and Arthritis Unit) in Guadalajara Jalisco Mexico. Determinations of ACPA were made with Eurodiagnostica ACPA plus kit. Anti-CarP determinations were made according to previously described protocols. RNA was isolated and purity and integrity determined according to RIN > 6. Gene expression analysis was made by RT-qPCR using specific primers for mRNAs of the type I IFN signature. Relative gene expression was calculated according to (Livak and Schmitgen). Results: Significant differences in gene expression were identified when comparing the different groups for MXA and MXB (p<0.05), also when comparing established RA and ACPA- in both IFIT 1 and G15. Increased expression of ISG15 was identified (p<0.05) and a clear tendency toward increase was identified for HERC5. EPSTRI1, IFI6 and IFI35 were found to be elevated in the cRA and eRA respectively (p<0.05). Significant correlations were identified for the IFN signature genes with the levels of ACPA and Anti-CarP (p<0.05). Conclusion: Our data confirms previous observations in the role of IFN signature and the pathogenesis of RA. Also, we provide evidence of an association between IFN-signature genes (that regulate Th2 cells and B cell proliferation) with the levels Anti-CarP and ACPA autoantibodies.
1 August 2011 in Human Immunology
1 April 2015 in Archives of Medical Research
GMGerardo Martínez-Aguilar
+8
27 March 2018 in PLOS ONE
Little is known regarding the mechanisms underlying the loss of tolerance in the early and preclinical stages of autoimmune diseases. The aim of this work was to identify the transcriptional profile and signaling pathways associated to non-treated early rheumatoid arthritis (RA) and subjects at high risk. Several biomarker candidates for early RA are proposed. Whole blood total RNA was obtained from non-treated early RA patients with 0.92. These genes come from several functional categories associated to inflammation, Wnt signaling and type I interferon pathways. The presence of a specific transcriptome in whole blood of RA patients suggests the activation of a specific inflammatory transcriptional signature in early RA development. The set of overexpressed genes in early RA patients that are shared with ACCP+ subjects but not with ACCP- subjects, can represent a transcriptional signature involved with the transition of a preclinical to a clinical RA stage. Some of these particular up-regulated and down-regulated genes are related to inflammatory processes and could be considered as biomarker candidates for disease progression in subjects at risk to develop RA.
1 January 2016 in Clinical Immunology
RGRosa Angélica González-Curiel
Rosa Angélica González-Curiel
VMVíctor Yordani Martínez-Balderas
Víctor Yordani Martínez-Balderas
+3